These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2979218)

  • 1. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer.
    Walt RP; Pounder RE; Hawkey CJ; Santana IA; Somerville KW; Logan RF; Long RG; Langman MJ
    Aliment Pharmacol Ther; 1987 Apr; 1(2):161-6. PubMed ID: 2979218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
    Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
    Howden CW; Tsai HH; Reid JL
    Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.
    Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG
    Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence.
    Bardhan KD; Morris P; Hinchliffe RF; Saunders JH; MacDougall BR; Bold JM; Freeman PR
    Aliment Pharmacol Ther; 1989 Oct; 3(5):489-97. PubMed ID: 2518862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of enprostil on the healing and the recurrence of duodenal ulcer. Comparison with ranitidine].
    Lartigue S; Corrion F; Bernades P; Bonfils S; Chevalier T; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
    Gastroenterol Clin Biol; 1994; 18(6-7):617-22. PubMed ID: 7875419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Svendsen LB; Rask-Madsen J
    Br Med J (Clin Res Ed); 1986 Mar; 292(6524):864-6. PubMed ID: 3083913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.
    Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C
    Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enprostil and ranitidine: comparative efficacy and safety in patients with duodenal ulcer.
    Mackinnon M; Alp M; Austad WI; Byrnes D; Cowen A; Duggan J; Pirola R; Thomas M; Ward M
    Aust N Z J Med; 1987 Jun; 17(3):316-20. PubMed ID: 3118861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
    Mahachai V; Walker K; Sevelius H; Thomson AB
    Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.
    Wagner S; Gladziwa U; Gebel M; Schüler A; Freise J; Schmidt FW
    Gut; 1991 Oct; 32(10):1104-9. PubMed ID: 1955162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of enprostil and ranitidine in treatment of duodenal ulcer.
    Bardhan KD; Lee FI; Bose K; Hinchliffe RF; Morris P; Thompson M; Whittaker L; Hardman M; Maxton DG; Colin R
    J Clin Gastroenterol; 1988 Apr; 10(2):137-42. PubMed ID: 3138303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
    J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
    Bianco A; Cagossi M; Piraccini R; Greco AV
    Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.
    Lauritsen K; Havelund T; Laursen LS; Bytzer P; Kjaergaard J; Rask-Madsen J
    Br Med J (Clin Res Ed); 1987 Apr; 294(6577):932-4. PubMed ID: 3107660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse].
    Bado A; Corrion F; Bernades P; Chevalier T; Galmiche JP; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
    Gastroenterol Clin Biol; 1994; 18(6-7):623-9. PubMed ID: 7875420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
    Peghini PL; Katz PO; Castell DO
    Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.